A NuGenia Logics publication · Free to read

Sarcopenia: Diagnosis, Clinical Implications, and Treatment Overview

Sarcopenia is recognized as a progressive skeletal muscle disorder characterized by a decline in muscle strength, muscle mass, and overall physical performance. As populations age, the clinical significance of sarcopenia is becoming more pronounced. This review highlights key aspects of sarcopenia diagnosis and management.

Diagnosis

According to the revised consensus from the European Working Group on Sarcopenia in Older People (EWGSOP2), muscle strength is central to the diagnosis of sarcopenia. The Sarcopenia Screening Questionnaire (SARC-F) is a useful tool for initial screening. Additionally, handgrip strength measurements can indicate reduced muscle strength, raising suspicion of sarcopenia.

To confirm the diagnosis and assess severity, muscle mass should be measured using dual-energy X-ray absorptiometry (DEXA) or bioelectrical impedance analysis. Functional tests are also employed to determine the severity of the condition. While biomarkers may assist in risk stratification, they do not replace the need for functional assessments.

Treatment

The most effective intervention for sarcopenia is progressive resistance training, which should be complemented by adequate protein intake, recommended at 1.2-1.5 g/kg of body weight per day, and correction of vitamin D deficiency. Currently, there are no specific pharmacological treatments approved for sarcopenia.

Preventive measures include regular physical activity, proper nutrition, management of comorbidities, and early mobilization. Recognizing sarcopenia early is crucial, as it is common and has significant prognostic implications, but it can be effectively managed through multimodal interventions.

What this study does not show

This review does not provide specific clinical trial data or outcomes related to the interventions discussed, limiting the ability to draw definitive conclusions about their effectiveness in diverse populations.

Evidence scorecard

  • Analytic validity: Established
  • Clinical validity: Partial
  • Clinical utility: Not established

The evidence is based on a review of existing literature and clinical guidelines.

Sponsored
Article slot — 728×90

Evidence classes are taken from source metadata — publication type and trial registration — never from opinion. How we classify · Corrections